Key Roundtable Takeaways

EXPLORE KEY TAKEAWAYS FROM ROUNDTABLE SESSIONS IN ISCT 2024 VANCOUVER

Designed to tackle the most pressing challenges and bottlenecks in Cell and Gene Therapy (CGT), the ISCT Roundtable Program leverages 
ISCT’s 40 standing expert committees to plan workshop-like sessions structured to generate solutions. Hosted by global key opinion leaders, these discussions have become an essential platform for delegates to exchange innovative ideas and advance solutions that address practical issues impeding the clinical translation of CGTs.

During ISCT 2024, 50 roundtable sessions sparked rich, solution-focused conversations across the global CGT landscape. ISCT is now posting key takeaways from these sessions for the benefit of the sector and to bring visibility to these critical discussions. Read these summaries to gain valuable insights into the challenges we are facing and the actionable solutions that will drive our sector forward.

As we look ahead to ISCT 2025, we invite you to explore the takeaways and gain a glimpse into the in-depth discussions that will continue at next year's event. Join us in shaping the future of CGT at ISCT 2025 New Orleans.


Basic & Discovery Research

Novel science with potential clinical implications.


The Clinic & Therapeutic Development

From bedside to bench and back again.  The critical role of clinical centers in innovating new therapies and insights into how new therapies are progressing.


Bioprocessing & Manufacturing

Developing and implementing an efficient and scalable manufacturing process.


Tools & Tech

Emerging trends in enabling manufacturing and analytical tools.


Regulation & Policy

Understanding the legislative underpinnings of regulatory authorities and how they impact critical regulatory policies and approaches.

GLOBAL REGULATORY PERSPECTIVES 

The Global Regulatory Perspectives (GRP) is a flagship ISCT program first established in 2007. These roundtables have been crafted using the expertise of the ISCT Global Regulatory Task force to bring together regulators and ISCT delegates from across the globe to work through complex case studies that offer practical insights into timely regulatory challenges.


Global CGT Markets

Establishing sustainable business models and cost structures to assure development, manufacturing and adoption of advanced therapies.


COGs & Business Models

Addressing the challenges of developing, manufacturing, and deploying advanced therapies in emerging CGT markets.


Workforce Development

Assuring our industry has a skilled and engaged workforce for years to come.